Abstract
Knowledge of the oxidative transformation of arachidonic acid into several distinct derivatives has increased considerably in recent years. The products consist of prostaglandins, prostacyclin (PGI2), thromboxanes, and leukotrienes (Samuelsson 1981). Arachidonic acid metabolites are biosynthesized in almost all mammalian tissues and exert a wide range of biological and pharmacological activities. They are therefore considered as powerful mediators in physiological processes. This has created a plethora of theories about their possible pathophysiological roles, and hopes were raised for the discovery of additional clues to the understanding and treatment of human diseases. Many of these expectations have turned into frustrations. Moreover, in spite of intensive research the significance of arachidonic acid metabolites in many processes has not yet been conclusively elucidated. In some areas, however, their involvement in biological events as modulators of ongoing biochemical activity has been defined. In this review, I will focus on some areas of clinical interest and discuss the possible significance of arachidonic acid metabolites in disease processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abate G, Polimeni RM, Cuccurullo F, Puddu P, Lenzi S (1979) Effects of indomethacin on postural hypotension in Parkinsonism. Br Med J 2:1466–1468
Anderson FL, Jubiz W, Tsagaris TJ, Kuida H (1975) Endotoxin-induced prostaglandin E and F release in dogs. Am J Physiol 228:410–414
Bartter FC, Propove P, Gill Jr JR, McCardle RC (1962) Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med 33:821–828
Beattie TJ, Murphy AV, Willoughby MLN, Belch JJF (1981) Prostacyclin infusion in haemolytic-uraemic syndrome of children. Br Med J 283–470
Bennett A (1971) Cholera and prostaglandins. Nature 231:536
Best LC, Holland TK, Jones PBB, Russell RGG (1980) The interrrelationship between thromboxane biosynthesis, aggregation, and 5-hydroxytryptamine secretion in human platelets in vitro. Thromb Haemost 43:38–40
Beubler E, Juan H (1979) Effect of ricinoleic acid and other laxatives on net water flux and prostaglandin E release by the rat colon. J Pharm Pharmacol 31:681–685
Brash AR, Hickey DE, Graham TP, Stahlman MT, Oates JA, Cotton RB (1981) Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus ateriosus. N Engl J Med 305:67–72
Brereton HD, Haluschka PV, Alexander RW, Mason DM, Keiser HR, De Vita V Jr (1974) Indomethacin-responsive hypercalcemia in a patient with renal-cell adeno- carcimoma. N Engl J Med 291:83–85
Brezin JH, Katz SM, Schwartz AB, Chinitz JL (1979) Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 301:1271–1273
Bruch HP, Schmidt E, Laven R, Kehrer G, Wasner KH (1978) The role of prostaglandins in peristalsis of the human colon. Acta Hepatogastroenterol (Stuttg) 25: 303–307
Bruch JW, Stanford N, Majerus PW (1978) Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 61:314–319
Butkus A, Skrinska VA, Schumacher OP (1980) Thromboxane production and platelet aggregation in diabetic subjects with clinical complications. Thromb Res 19:211–223
Canadian Cooperative Study Group (1978) A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 299:53–59
Cantieri JS, Graff G, Goldberg ND (1980) Cyclic GMP metabolism in psoriasis: activation of soluble epidermal guanylate cyclase by arachidonic acid and 12-hydro- xy-5,8,10,14-eicosatetraenoic acid. J Invest Dermatol 74:234–237
Chaudhury TK, Jacobson ED (1978) Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 74:59–63
Chen Y-C, McLeod B, Hall ER, Wu KK (1981) Accelerated prostacyclin degradation in thrombotic thrombocytopentic purpura. Lancet 2:267–269
Clifford PC, Martin MFR, Sheddon EJ, Kirby JD, Baird RN, Dieppe PA (1980) Treatment of vasospastic disease with prostaglanin E1. Br Med J 281:1031–1034
Cooke RA (1919) Allergy in drug idiosyncrasy. JAMA 73:759
Coombes RC, Neville AM, Bondy PK, Powles TJ (1976) Failure of indomethacin to reduce hyddoxyproline excretion or hypercalcemia in patients with breast cancer. Prostaglandins 12:1027–1035
Cooper B (1979) Diminished platelet adenylate cyclase activation by prostaglandin D2 in acute thrombobosis. Blood 54:684–693
Cooper B, Ahern D (1979) Characterization of the platelet prostaglandin D2 receptor. J Clin Invest 64:586–590
Cooper B, Schafer AI, Puchalsky D, Handin RI (1978) Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders. Blood 52:618–626
Dahlen SE, Björk J, Hedgrist P, Arfors KE, Hammarström S, Lindgren JA, Samuelsson S (1981) Leukotrienes promote plasma leakage and leukocycte adhesion in post-cappillary venules. In vivo effects with relevance to the acute inflammatory response. Proc Natl Acid Sci USA 78:3887–3891
Davenport HW (1970) Back diffusion of acid through the gastric mucosa and its phyiological consequence. In: Glass GB (ed) Progress in gastroenterology, vol 11. Grund & Stratton, New York, pp 42–56
Dawood MY (1981) Dysmenorrhoea and prostaglandines. Pharmacological and therapeutic considerations. Drugs 22:42–56
Demis JD (1963) The mastocytosis syndrome. Clinical and biological studies. Ann Intern Med 59:194–206
Downing I, Shepherd GL, Lewis PJ (1980) Prostaglandin production is reduced in preeclampsia. Lancet 2:1374
Dowsett M, Easty GC, Powles TJ, Easty DM, Neville Am (1976) Human breast tumour-induced osteolysis and prostaglandins. Prostaglanins 11:447–460
Dunn MJ, Hood VL (1977) Prostaglandins and the kidney. Am J Physiol 233: F169–F184
Durao V, Prata MM, Goncalves LMP (1977) Modification of antihypertensive effect of beta-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet 11:1005–1007
Dyerberg J, Bang HO (1979) Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 2:433–435
Elam MB, Lipscomb GE, Chesney CM, Terragno DA, Terragno NA (1980) Effect of synthetic estrogen on platelet aggregation and vascular release of PGI2-like material in the rabbit. Prostaglanins 20:1039–1051
Ellis CK, Smigel MD, Oates JA, Oelz O, Sweetman BJ (1979) Metabolism of prostaglandin D2 in the monkey. J Biol Chem 254:4152–4163
Ellis EF, Oelz Ö, Jackson L II, Payne NA, Sweetman BJ, Nies AS, Oates JA (1976) Coronary arterial smooth muscle contraction by a substance released from platelets. Evidence that it is thromboxane A2. Science 193:1135–1137
Feldberg WKP (1973) Pyrogen fever and prostaglandin-like activity in cerebrospinal fluid. J Physiol 228:41–53
Ferreira SH, Herrman A, Vane JR (1972) Prostaglandin generation maintains the smooth muscle tone of the rabbit isolated jejunum. Br J Pharmacol 44:328
Fitzgerald GA, Maas RL, Stein R, Oates JA, Roberts LJ (1981) Intravenous prostacyclin in thrombotic thrombocytopenic purpura. Ann Intern Med 95:319–322
Franklin RB, Tashjian AH Jr (1975) Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat. Endocrinology 97:240–243
Friedman PL, Brown EJ Jr, Gunther S, Alexander RW, Barry WH, Mudge GH Jr, Grossman W (1981) Coronary vasoconstrictor effect of indomethacin in patients with coronary-artery disease. N Engl J Med 305:1171–1175
Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE (1976) Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 295:256–529
Friesinger GC, Oelz O, Sweetman BJ, Nies AS, Data JL (1978) Prostaglandin D2, another renal prostaglandin? Prostaglandins 15:969–981
Frishman WH, Christodoulou J, Weksler B, Smithen C, Kilip T, Scheidt S (1976) Aspirin therapy in angina pectoris: effects on platelet aggregation, exercise tolerance, and electrocardiographic manifastations of ischemia. Am Heart J 92: 3–10
Frölich JC (1981) Zur Rolle der Prostaglandine bei der Reninfreisetzung. Klin Wochenschr 59:1139–1147
Fung WP, Karim SMM (1976) Effect of 15 (R) 15 methyl prostaglandin E2 on the healing of gastric ulcers — Double-blind endoscopic study. Med J Aust 2:127–128
Gary NE, Dodelson R, Eisinger RP (1980) Indomethacin-associated acute renal failure. Am J Med 69:135–136
Gerber JG, Branch RA, Hubbard WC, Nies AS (1978) Indomethacin is a placental vasodilator in the dog. The effect of prostaglandin inhibition. J Clin Invest 62: 14–19
Gerrard JM, Stuart MJ, Rao GHR, Steffes MW, Mauer SM, Brown DM, White JG (1980) Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med 95:950–958
Gill JR Jr (1980) Bartter’s syndrome. Annu Rev Med 31:405–419
Gill JR Jr Frölich JC, Bowden RE, Taylor AA, Keiser HR, Seyberth HW, Oates JA, Bartter FC (1976) Bartter’s syndrome: A disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med 61:43–51
Goetzl EJ (1980) The generation of mediators of immediate-type hypersensitivity by the lipoxygenation of arachidonic acid. N Engl J Med 303:822–825
Goldberg M, Murray TG (1978) Analgesic-associated nephropathy, an important cause of renal disease in the United States. N Engl J Med 294. 716–717
Gomes BC, Hausmann E, Weinfeld N, De Luca C (1976) Prostaglandins: Bone resorption stimulating factors released from monkey gingiva. Calcif Tissue Res 19: 285–293
Gots RE, Formal SB, Giannelly RA (1974) Indomethacin inhibition of Salmonella typhimurium, Shigella flexneri, and cholera-mediated rabbit ileal secretion. J Infect Dis 130:280–284
Grose JH, Lebel M, Gbeassor FM (1980) Variations in urinary metabolites of prostacyclin and thromboxane A2 in essential hypertension. Clin Res 28:685A
Gross DM, Brookins J, Fink GD, Fisher JW (1976) Effects of prostaglandins A2, E2, and F2α, on erythropoietin production. J Pharmacol Exp Ther 198:489–496
Grossman MI, Kurata JH, Rotter JI, Meyer JH, Robert A, Richardson CT, Debas HT, Jensen DM (1981) Peptic ulcer: New therapies, new diseases. Ann Intern Med 95:609–627
Güllner H-G, Cerletti C, Bartter FC, Smith JB, Gill JR Jr (1979) Prostacyclin overproduction in Bartter’s syndrome. Lancet 11:767–768
Halushka PV, Lurie D, Colwell JA (1977) Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. N Engl J Med 297: 1306–1310
Halushka PV, Rogers RC, Loadholt CB, Colwell JA (1981) Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97:87–96
Ham EA, Cirillo VJ, Zanetti ME, Kuehl JR (1975) Estrogen-directed synthesis of specific prostaglandins in uterus. Proc Natl Acad Sci USA 72:1420
Hamberg M, Samuelsson B (1973) Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci USA 70:899–903
Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 72:2994–2998
Hamberg M, Svensson J, Hedgrist P, Strandberg K, Samuelssson B (1976) Involement of endoperoxides and thromboxanes in anaphylactic reactions. Adv. Prostaglandin Thromboxane Res 1:495–501
Hammarstrom S, Hamberg M, Samuelsson B, Duell EA, Stawiski M, Voorhees JJ (1975) Increased concentrations of nonesterified arachidonic acid. 12L-hydroxy- 5,8,10 14-eicosatetraenoic acid, prostaglandin E, and prostaglandin F2α in epidermis of psoriasis. Proc Natl Acad Sci USA 72:5130–5134
Hammarstrom S, Hamberg M, Duell EA, Stawiski M, Anderson TF, Voorhees JJ (1977) Glucocorticoid in inflammatory proliferative skin desease reduces arachidonic and hydroxyeicosatetraenoic acids. Science 197:994–996
Harris DW, Swan CH (1977) Increased synthesis of prostaglandin in ulcerative colitis (Letter) Lancet II 196
Harris WH, Salzman EW, Athanasoulis CA, Waltman AC, DeSanctis RW (1977) Aspirin prophylaxis of renous thromboembolism after total hip replacement. N Engl J Med 297:1246–1249
Haslam RJ, McClenaghan MD (1981) Measurement of circulating prostacyclin. Nature 292:364–366
Heymann MA, Rudolp AM, Silverman NH (1976) Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 295: 530–533
Higgs GA, Eakins KE, Mugridge KG, Monceda S, Vane JR (1980) The effect of nonsteroid anti-inflammatory drugs on leukocycte migration in carrageenin-induced inflammation. Eur J Pharmacol 66:81–86
Hinsdale JG, Engel JJ, Wilson DE (1974) Prostaglandin E in peptic ulcer disease. Prostaglandins 6:495–500
Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT (1981) Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 304:685–691
Hong SL, Levine L (1976) Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci USA 73:1730–1734
Horns DJ, Gerrard JM, Rao GH, Krivit W, White JG (1976) Smoking and platelet labile aggregation stimulating substance (LASS) synthesizing activity. Thromb Res 9:661–668
Jackson EK, Herzer WA, Zimmerman JB, Branch RA, Oates JA, Gerkens JF (1981) 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilotor and renin secretagogue. J Pharmacol Exp Ther 216:24–27
Jacoby HI, Marshall CH (1972) Antagonism of cholera enterotoxin by antiinflammatory agents in the rat. Nature 235:163–165
Jaffe BM, Condon S (1976) Prostaglandins E and F in endocrine diarrheagenic syndromes. Ann Surg 184:516–523
Karim SMM, Carter DC, Bhana D, Ganesan PA (1973) Effect of orally administered prostaglandin E2 and its 15-methyl analogues on gastric secretion. Br Med J 1:143–146
Kimberg DV, Field M, Gershon E, Henderson A (1974) Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of the toxin. J Clin Invest 53:941–949
Kimberly PR, Plotz PH (1977) Aspirin-induced depression of renal function. N Engl J Med 296:418–424
Kimberly RP, Gill JR Jr, Bowden RE, Keiser HR, Plotz PH (1978) Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus. Ann Intern Med 89:336–341
Klein DC, Raisz LG (1970) Prostaglandins: Stimulation of bone resporption in tissue culture. Endocrinology 86:1436–1440
Klickstein LB, Shapleigh C, Goelzl EJ (1980) Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest 66:1166–1170
Kochar MS, Itskovitz HD (1978) Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Lancet 1:1011–1014
Kuehl FA Jr, Egan RW (1980) Prostaglandins, arachidonic acid, and inflammation. Science 210:978–984
Lands WEM (1979) The biosynthesis and metabolism of prostaglandins. Annu Rev Physiol 41:633–652
Larrue J, Rigaud M, Daret D, Demond J, Durand J, Bricaud H (1980) Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aorta. Nature 285:480–482
Lewis RA, Roberts LJ II, Holgate ST, Oates JA, Austen KF (1980) Prostaglandin D2 production by rat and human mast cells activated by reversed anaphylaxis. Fed Proc 39:905 (abstract)
Lewy RI, Smith JB, Silver MJ, Saia J, Walinsky P, Wiener L (1979) Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal’s angina. Clin Res 27:462A
Lippiello L, Yamamoto K, Robinson D, Mankin HJ (1978) Involvement of prostaglandins from rheumatoid synovium in inhibition of articular cartilage metabolism. Arthritis Rheum 21:909–917
Longmore DB, Bennett JG, Hoyle PM, Smith MA, Gregory A, Osivand T, Jones WA (1981) Prostacyclin administration during cardiopulmonary bypass in man. Lancet 1:800–804
Machin SJ, Carreras LO, Chamone DAF, Defreyn G, Dauden M, Vermylen J (1980) Familial deficiency of thromboxane synthetase. Acta Ther 6:34 (abstract)
Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI (1982) Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 306:506–510
Malmsten C, Hamberg M, Svensson J, Samuelsson B (1975) Physiological role of an endoperoxide in human platelets: Hemostatic defect due to platelet cyclo- oxygenase deficiency. Proc Natl Acad Sci USA 72:1446–1450
Matuschansky C, Bernier JJ (1973) Effect of prostaglandin E1 on glucose, water and electrolyte absorption in the human jejunum. Gastroenterology 64:1111–1118
Mitchell JR, McMurtry RJ, Statham CN, Nelson SD (1977) Molecular basis for several drug-induced nephropathies. Am J Physiol 62:518–526
Miwa K, Kambara H, Kawai C (1981) Exercise-induced angina provoked by aspirin administration in patients with variant angina. Am J Cardiol 47: 1210–1214
Molland EA (1978) Experimental renal papillary necrosis. Kidney Int 13:5–14
Moncada S, Vane JR (1979) Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med 300:1142–1147
Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263:663–665
Moncada S, Herman AH, Higgs EA, Vane JR (1977) Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the antithrombotic properties of vascular endothelium. Throm Res 11:323–344
Morris HR, Taylor GW, Piper PJ, Tippins JR (1980) Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature 285:104–106
Murphy RC, Hammarstrom S, Samuelsson B (1979) Leukotriene C: A slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 76:4275–4279
Neal WA, Kyle JM, Mullett MD (1977) Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 91:621–623
Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher H (1979) Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci USA 76:944–948
Nijkamp FP, Flower RJ, Moncada S, Vane JR (1976) Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids. Nature 263:479–482
Nordoy A, Svensson B, Haycraft D, Hoak JC, Wiebe D (1978) The influence of age, sex, and the use of oral contraceptives on the inhibitory effects of endothelial cells and PGI2 (prostacyclin) on platelet function. Scand J Haematol 21:177–187
Oelz O, Seyberth HW, Knapp HR Jr, Sweetman BJ, Oates JA (1976) Effects of feeding ethyl-dihomo-y-linolenate on prostaglandin biosynthesis and platelet aggregation in the rabbit. Biochim Biophys Acta 431:268—277
Oelz O, Oelz R, Knapp HR, Sweetman BJ, Oates JA (1977) Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins 13:225–234
Oerning L, Hammarstrom S, Samuelsson B (1980) Leukotriene D: A slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci USA 77:2014–2017
Ogawa K, Ito T, Enomoto I, Hashimoto H, Kai T, Satake T (1980) Increase of coronary flow and levels of PGE1 and PGF2α, from the ischemic area of experimental myocardial infarction. Adv Prostaglandin Thromboxane Res 7:665–669
Oliva PB (1981) Pathophysiology of acute myocardial infarction, 1981. Ann Intern Med 94:236–250
Olley PM, Coceani F (1981) Prostaglandins and the ductus arteriosus. Annu Rev Med 32:375–385
Palmblad J, Malmsten CL, Uden A-M, Radmark O, Engstedt L, Samuelsson B (1981) Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 58:658–661
Patak RV, Mookerjee BK, Bentzel CJ, Hysert PE, Babej M, Lee JB (1975) Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 10:649–659
Patrono C, Cinotti G A, Ciabattoni G, Pugliese F (1980) Prostaglandins, thromboxanes, and renal physiology: introduction. In: Remuzzi G, Mecca G, de Gaetano G (eds) Hemostasis, prostaglandins, and renal disease. Raven, New York, pp 151–157
Patrono C, Pugliese F, Ciabattoni G, Patrignani P, Maseri A, Chierchia S, Peskar BA, Cinotti GA, Simonetti BM, Pierucci A (1982) Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest 69:231–239
Pick R, Chediak J, Glick G (1979) Aspirin inhibits development of coronary atherosclerosis in cynomolgus monkeys (Macaca Fascicularis) fed an atherogenic diet. J. Clin Invest 63:158–162
Plaksin J, Landau Z, Coslovsky R (1980) A carcinoid-like syndrome causd by a prostaglandin-secreting renal cell carcinoma. Arch Intern Med 140:1095–1096
Prickett JD, Robinson DR, Steinberg AD (1981) Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice. J Clin Invest 68: 556–559
Raisz LG, Sandberg AL, Goodson JM, Simmons HA, Mergenhagen SE (1974) Complement-dependent stimulation of prostaglandin synthesis and bone resorption. Science 185:789–791
Rane A, Oelz O, Frölich JC, Seyberth HW, Sweetman BJ, Watson JT, Wilkinson GR, Oates JA (1978) Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther 23:658–668
Rattan S, Goyal RK (1980) Role of prostaglandins in the regulation of lower esophageal sphincter. In: Christensen JC (ed) Proceedings of the seventh international symposium on gastrointestinal motility. Raven, New York, pp 234–242
Remuzzi G, Mecca G, Marchesi D, Livio M, de Gaetano G, Donati MB, Silver MJ (1979) Platelet hyperaggregability and the nephrotic syndrome. Throm Res 16: 345–354
Richardson TJ, Sgoutas D (1975) Essential fatty acid deficiency in four adult patients during total parenteral nutrition. Am J Clin Nutr 28:258–263
Robert A, Nezamis JE, Phillips JP (1967) Inhibition of gastric secretion by prostaglandins. Am J Dig Dis 12:1073–1076
Robert A, Nezamis JE, Lancaster C (1976) Effect of 16, 16-dimethyl PGE2 on gastric emptying. Prostaglandin Thromboxane Res 2:946
Robert A, Nezamis JE, Lancaster C, Handar AJ (1979) Cytoprotection by prostagla- dins in rats. Prevention of gastric necrosis produced by alcohol, HC1, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77:433–443
Roberts LJ II, Sweetman BJ, Morgan JL, Payne NA, Oates JA (1977) Indentification of the major urinary metabolite of thromboxane B2 in the monkey. Prostaglandins 13:631–647
Roberts LJ II, Hubbard WC, Bloomgarden ZT, Bertagna XY, McKenna TJ, Rabinowitz D, Oates JA (1979) Prostaglandins: Role in the humoral manifestations of medullary carcinoma of the thyroid and inhibition by somatostatin. Trans Assoc Physicians 92:286–291
Roberts LJ II, Sweetman BJ, Lewis RA, Austen KF, Oates JA (1980) Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 303:1400–1404
Robertson RM, Robertson D, Roberts LJ, Maas RL, Fitzgerald GA, Friesinger GC, Oates JA (1981) Thromboxane A2 in vasotonic angina pectoris. Evidence from direct measurements and inhibitor trials. N Engl J Med 304:998—1003
Robertson RP, Chen M (1977) A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest 60:747–753
Robertson RP, Guest RJ (1978) Reversal by methysergide of inhibition of insulin secretion by prostaglanin E in the dog. J Clin Invest 62:1014–1019
Robinson DR, Tashjian AH Jr, Levine L (1975) Prostaglandin-stimulated bone resorptiion by rheumatoid synovia: A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 56:1181–1188
Rosenkranz B, Fischer C, Weimer KE, Frölich JC (1980) Metabolism of prostacyclin and 6-keto-prostaglandin F1α in man. J Biol Chem 255: 10194–10198
Rybicka J, Gibinski K (1978) Methyl-prostaglandin E2 analogues for healing of gastroduodenal ulcers. Scand J Gastroenterol 13:155–159
Samter M, Beers RF (1968) Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 68:975–983
Samuelsson B (1973) Quantitative aspects on prostaglandin synthesis in man. Adv Biosci 9:7–14
Samuelsson B (1981) Prostaglandins, thromboxanes, and leukotrienes: formation and biological roles. Harvey Lec 75:1–40
Samuelsson B, Granström E, Green K, Hamberg M (1971) Metabolism of prostaglandins. Ann NY Acad Sci 180:138–163
Samuelsson B, Goldberg M, Granström E, Hamberg M, Hammarstrom S, Molmsten C (1978) Prostaglandins and thromboxanes. Annu Rev Biochem 47:997–1029
Schafer AI (1982) Deficieny of platelet lipoxygenase activity in myeloproliferative disorders. N Engl J Med 306:381–386
Schafer AI, Cooper B, O’Hara D, Handin RI (1979) Indentification of platelet receptors for prostaglandin I2 and D2. J Biol Chem 254:2914–2917
Seyberth HW (1978) Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome. Klin Wochenschr 56:373–387
Seyberth HW, Oelz O, Kennedy T, Sweetman BJ, Danon A, Frölich JC, Heimberg M, Oates JA (1975a) Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin Pharmacol Ther 18:521–529
Seyberth HW, Segre GV, Morgan JL, Sweetman BJ, Potts JT Jr, Oates JA (1975b) Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med 293:1278–1283
Seyberth HW, Segre GV, Hamet P, Sweetman BJ, Potts JT Jr, Oates JA (1976) Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors. Trans Ass Am Physicians 89:92–104
Seyberth HW, Hubbard WY, Oelz O, Sweetman BJ, Watson JT, Oates JA (1977) Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit. Prostaglandins 14:319–331
Sharon P, Ligumsky M, Rachmilewitz D, Zor U (1978) Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 75:638–640
Siess W, Roth P, Scherer B, Kurzmann I, Böhlig B, Weber PC (1980) Platelet membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet. Lancet 1:441–444
Silverberg AB, Mennes PA, Cryer PE (1978) Resistance to endogenous norepinephrine in Bartter’s syndrome. Reversion during indomethacin adiminstration. Am J Med 64:231–235
Simon B, Seitz H, Kather H (1980) Effects of PG E2 and PG I2 on the adenylate cyclase activity in rat intestinal epithelial cells. Biochem Pharmacol 29:673–675
Smith AP, Cuthbert MF (1976) The response of normal and asthmatic subjects to prostaglandins E2 and F2α: by different routes, and their significance in asthma. Prostaglandin Thromboxane Res 449
Smith PR, Dawson DJ, Swan CHJ (1978) Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone. Gut 20:802–805
Stenson WF, Lobos E (1982) Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest 69:494–497
Stuart MJ, Gerrad JM, White JG (1980) Effect of cholesterol on production of thromboxane B2 by platelets in vitro. N Engl J Med 302:6–10
Stuart MJ, Clark DA, Sunderji SG, Allen JB, Yambo T, Elrad H, Slott JH (1981) Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndromes. Lancet 1:1126–1128
Sun FF, Taylor BM (1981) Metabolism of prostacyclin in cynomolgus monkey. Prostaglandins 21:307–314
Swartz SL, Williams GH, Hollenberg NK, Levine L, Dluhy RG, Moore TJ (1980) Captopril-induced changes in prostaglandin production. J Clin Invest 65:1257–1264
Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G (1975) Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1:67
Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G (1977) Clinical patterns of hypersensitivity to non-steroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 60:276–284
Szczeklik A, Gryglewski RJ, Musial J, Grodzinska L, Serwonska M, Marcinkiewiez E (1978) Thromboxane generation and platelet aggregation in survivals of myocardial infarction. Thromb Haemost 40:66–74
Szczeklik A, Nizankowski R, Skawinski S, Szczeklik J, Gluszko P, Gryglewski RJ (1979) Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet 1:1111–1114
Tan SY, Sweet P, Mulrow PJ (1978) Impaired renal production of prostaglandin E2: a newly identified lesion in human essential hypertension. Prostaglandins 15:139–149
Tashjian AH Jr, Voelkel EF, Levine L, Goldhaber P (1972) Evidence that bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E2: A new model for the hypercalcemia of cancer. J Exp Med 136:1329–1343
Thornburn GD, Challis JRG (1979) Endocrine control of parturition. Physiol Rev 59: 863
Turney JH, Williams LC, Fewell MR, Parsons V, Weston MJ (1980) Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy. Lancet 2: 219–222
Tyler HM, Saxton CAP, Parry MJ (1981) Administration to man of UK-37, 248-01, a selective inhibitor of thromboxane synthetase. Lancet 1:629–632
Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature [New Biol] 231:232–235
Vermylen J, Defreyn G, Carreras LO, Machin SJ, Schaeren JV, Verstraete M (1981) Thromboxane synthetase inhibition as antithrombotic strategy. Lancet 1:1073–1075
Voelkel EF, Tashjian AH Jr, Franklin R, Wasserman E, Levine L (1975) Hypercalcemia and tumor-prostaglandins: The VX2 carcinoma model in the rabbit. Metabolism 24:973–986
Walshe JJ, Venuto RC (1979) Acute oliguric renal failure induced by indomethacin: possible mechanism. Ann Intern Med 91:47–49
Webster J, Ress AJ, Lewis PJ, Hensby CN (1980) Prostacyclin deficiency in haemoly- tic-uraemic syndrome. Br Med J 282:271
Weiss HJ, Lages BA (1977) Possible congenital defect in platelet thromboxane synthetase. Lancet 1:760–761
Wene JD, Connor WE, DenBesten L (1975) The development of essential fatty acid deficiency in healthy men fed fat-free diets intravenously and orally. J Clin Invest 56:127–134
Wennmalm A (1980) Nicotine inhibits hypoxia- and arachidonate-induced release of prostacyclin-like activity in rabbit hearts. Br J Pharmacol 69:545–549
Willman EA, Collins WP, Clayton SG (1976) Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br J Obstet Gynaec 83:337
Wilson DE, Phillips C, Levine RA (1971) Inhibition of gastric secretion in man by prostaglandin A1. Gastroenterology 61:201–206
Wilson DE, Quertermus J, Raiser M, Curran j, Robert A (1976) Inhibition of stimulated gastric secretion by an orally administered prostaglandin capsule: A study in normal men. Ann Intern Med 84:688–691
Winther J, Printz MP, Mendoza SA, Kirkpatrick SE, Friedman WF (1977) The influence of indomethacin on neonatal renal function. Pediatr Res 11:402
Wortman DW, Kelsch RC, Kuhns L, Sullivan DB, Cassidy JT (1980) Renal papillary necrosis in juvenile rheumatoid arthritis. J Pediatr 97:37–40
Yeh TF, Luken JA, Thalji A, Raval D, Carr T, Pildes RS (1981) Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus — a double-blind controlled study. J Pediatr. 98:137–145
Yoshida N, Aoki N (1978) Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome. Blood 52:969–977
Zipser RD, Hoefs JC, Speckart PF, Zia PK, Horton R (1979) Prostaglandins: Modulators of renal function and pressor resistance in chronic liver disease. J Clin Endocrinol Metab 48:895–900
Zusman RM (1981) Prostaglandins and water excretion. Annu Rev Med 32:359–374
Zusman RM, Rubin RH, Cato AE, Cocchetto DM, Crow JW, Tolkoff-Rubin N (1981) Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 304:934–939
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Oelz, O. (1982). The Clinical Significance of Arachidonic Acid Metabolites. In: Frick, P., von Harnack, GA., Kochsiek, K., Martini, G.A., Prader, A. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde / Advances in Internal Medicine and Pediatrics. Ergebnisse der Inneren Medizin und Kinderheilkunde/ Advances in Internal Medicine and Pediatrics, vol 50. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68546-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-68546-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68548-4
Online ISBN: 978-3-642-68546-0
eBook Packages: Springer Book Archive